A double-blind, randomized, placebo-controlled, parallel study to evaluate the efficacy and safety of imidafenacin in patients with overactive bladder in Taiwan
Journal
LUTS: Lower Urinary Tract Symptoms
Journal Volume
13
Journal Issue
1
Pages
108-117
Date Issued
2021
Author(s)
Abstract
Objective: This study evaluated the efficacy and safety of imidafenacin 0.1 mg twice daily vs placebo for Taiwanese patients with overactive bladder (OAB) after a 12-week oral administration. Methods: This randomized, double-blind, placebo-controlled, two
Subjects
adverse events; antimuscarinics; overactive bladder; pharmacotherapy
SDGs
Other Subjects
imidafenacin; placebo; imidafenacin; imidazole derivative; urinary tract agent; adult; allergic conjunctivitis; Article; backache; constipation; controlled study; diarrhea; double blind procedure; drug efficacy; drug safety; drug screening; dry eye; femal
Publisher
Blackwell Publishing
Type
journal article